Navigation Links
Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
Date:10/14/2009

PITTSBURGH, Oct. 14 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) announced today that it will host a conference call and live webcast on Thursday, Oct. 29, 2009, at 10:00 a.m. ET, to review the company's financial results for the third quarter 2009, which ended Sept. 30. Mylan will release its financial results on Oct. 29 before the market opens.

The dial-in number to access the Oct. 29 call is 877.874.1586 or 719.325.4775 for international callers. A replay, available for approximately seven days, will be available at 888.203.1112 or 719.457.0820 for international callers with access pass code 6781546.

To access a live webcast of the call, please log on to Mylan's Web site (www.mylan.com) at least 15 minutes before the event is to begin to register and download or install any necessary software. A replay of the webcast will be available on www.mylan.com for approximately seven days.

Mylan Inc. ranks among the leading generic and specialty pharmaceutical companies in the world and provides products to customers in more than 140 countries and territories. The company maintains one of the industry's broadest and highest quality product portfolios supported by a robust product pipeline; operates the world's third largest active pharmaceutical ingredient manufacturer; and runs a specialty business focused on respiratory and allergy therapies. For more information, please visit www.mylan.com.

SOURCE Mylan Inc.


'/>"/>
SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine technology :

1. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
2. Schering-Plough Schedules Conference Call Webcast For 2009 Third Quarter Earnings
3. Misonix Schedules Fourth Quarter and Fiscal Year 2009 Financial Results Conference Call; October 1, 2009 at 4:30 p.m. Eastern
4. Orexigen(R) Therapeutics Schedules September 30, 2009 Teleconference and Webcast to Discuss Phase 2b Trial Results From Second Obesity Drug Candidate, Empatic(TM)
5. Orexigen(R) Therapeutics Schedules July 20, 2009 Teleconference and Webcast Discussion of Contrave(R) Phase 3 Results
6. Wyeth Applauds Six Countries Across Europe, and the Middle East, That Recently Announced the Inclusion of the 7-Valent Pneumococcal Conjugate Vaccine (PCV7) in Their Immunization Schedules
7. MDS Patients on Five-Day Vidaza(R) Dosing Schedules Achieve Transfusion Independence Consistent with Seven-day Schedule
8. Medizone International Announces Third Round of AsepticSure
9. Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast
10. Boston Scientific to Webcast Conference Call Discussing Third Quarter Financial Results
11. Endo Pharmaceuticals to Announce Third Quarter 2009 Financial Results on October 29, 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...wswire-FirstCall/--Pharmasset,Inc.(Nasdaq: VRUS ),...overing,developingandcommercializingnoveldrugstotr...iscalyearendedSeptember30,2009.AtSeptember30,2009P...shortterminvestments. ,, PipelineUpdateand2009...,, InlateNovember2009,anindependentDataMonitori...
(Date:11/25/2009)...e/--BioTrendsResearchGroup,Inc.releasedWave1ofits ...ulti-phasesyndicatedmarketresearchprojecttrackingt...ctlaunchthroughthefirstsixmonthsofavailability.Eac...m75uniqueDermatologistsandqualitativeinformationfr...,obstaclestouse,typicalpatienttypes,productpercept...
(Date:11/25/2009)...ewswire-USNewswire/--RemediumTechnologiesInc.,acom...ebleeding,wonfirstprizeand$10,000intheMostPromisin...009,companyofficialsannouncetoday. ,, Selectedf...teampitchedtheirinventionattheGSCSecuritySummitcon...dium( www.remediumtechnologies.com )isdevelopingah...
Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Despite Managed Care Obstacles, Interest and Anticipated Use of Centocor Ortho-Biotech's New Psoriasis Agent Stelara (ustekinumab) is High 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Group B Strep Screening Guidelines Sparing Newborns 49294 1Group B Strep Screening Guidelines Sparing Newborns 49294 2Group B Strep Screening Guidelines Sparing Newborns 49294 3Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 1Renaissance America Tracks Trend on Loss of Retiree Benefits in New Whitepaper 49291 2Amylin Pharmaceuticals to Present at Piper Jaffray Europe Conference 12680 1
...he Food and Drug,Administration (FDA) Cardiovascul...Drug Safety and Risk Management Advisory Committee...to erythropoiesis-stimulating,agents (ESA,s), Orth... key,issues that will be discussed: * The studies...luated hemoglobin targets above 13 grams per de...
...lerability with No Clinically Significant ...erence Call Scheduled for 8:30AM (ET) Today-, PRI... VRUS ) is presenting safety, tolerability, pharma...cending doses of R7128 at the 14th,International S...being held,from September 9-13, 2007 in Glasgow, S...
Other Medicine Technology:Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 2Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 3Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 4Ortho Biotech Reiterates Confidence in PROCRIT(R) (Epoetin alfa) Safety and Efficacy When Used According to Label 5Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 2Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 3Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 4Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers 5
(Date:11/25/2009)...to overlook needed care, study finds , ,... depression can worsen her child,s asthma, U.S. re...f 262 black mothers and their children found that ...s had more frequent asthma symptoms, while childre...ss frequent asthma symptoms. , The Johns Hopkin...
(Date:11/25/2009)...ONSkincare ®isproudtosupportGNC,seffortstorai...t.Jude ThanksandGiving campaign,$1fromthepurchasep...Balm willbedonatedtoSt.Jude.Additionally,GNCcustom...eckoutatoneoftheir5,000+retaillocationsoratGNC.com...heir2009 ThanksandGiving campaign. ,, "Wearedel...
(Date:11/25/2009)...ried into the body on a carefully engineered, fing...eliminate tumors in mammals, scientists report thi...ine . , The new approach, pioneered by bioengine...plastic disks impregnated with tumor-specific anti... mammalian immune system to attack tumors. The new...
(Date:11/25/2009)...tumor cells, study finds , , WEDNESDAY, ...ered in a fingernail-size implant eliminated melan...method uses polymer disks, 8.5 millimeters in diam... and implanted under the skin to reprogram the imm...y scientists who developed the implant predicted t...
(Date:11/25/2009)...ds to include cost-effective, sustainable distance...rofessionals in developing world. , ...9 -- Elluminate, Inc. , the leader in web, audio...ort 21st century teaching, learning, and collabora...iative was awarded iNACOL,s first-ever Outstandin...
Breaking Medicine News(10 mins):Health News:Mom's Depression May Worsen Child's Asthma 2Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2Health News:Implant-based cancer vaccine is first to eliminate tumors in mice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 2Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 3Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 4Health News:Elluminate's Fire and Ice Project Recognized as First-Ever iNACOL Award Winner for Outstanding and Most Innovative Online Learning Practice 5
... BOSTON Since the days of Hippocrates, people hav...e seasons. More recently, researchers have learned...s seasonality, are often related to the weather. I...he Department of Public Heath and Family Medicine ...
...OS GATOS, Calif., Sept. 12 Death may be the last ...ked about. It is usually looked,upon as something ...but,Philip and Darlyne intend to tear down the wal...ng death and Philip,s loss. They have written this...
...Using all natural guacamole as a dip or condiment ... - September 16 , November 14)-, DALLAS, Sept. 12...inking -- avocados are great for you. (Photo: ht... -- and loaded with lutein which protects,against ...
...ONTREAL, Sept. 12 /PRNewswire/ - The Montreal-base... (ISIVF) will host the 14th World,Congress on In V...ess on,In-Vitro Maturation (IVM), at the Fairmont ...ogists in the field of,human fertility. "As IVF a...
...aiser Family Foundation: Premiums increased at slo...h insurance,premiums increased at the slowest pace...ar premium increases have declined, according to a...nnual Survey found,that health insurance premiums ...
...ACKSONVILLE, Fla., Sept. 11 In remarks presented ...,s (BCBSF) annual,policyholders, meeting, Chris Do...e Officer and Chief Financial Officer, reported th...(Logo: http://www.newscom.com/cgi-bin/prnh/200004...
Other Medicine News:Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2Health News:Guacamole: Fights Hunger, Cholesterol and Cancer 2Health News:World fertility experts to meet in Montreal - IVF and IVM patients to provide first-person accounts at 14th World Congress 2Health News:Health Insurance Premium Growth Slows for Fourth Straight Year 2Health News:Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance 2
Diamond Burr - Round
Pterygium Diamond Burr
Ruedemann Lacrimal Dilator
Wilder Lacrimal Dilator - Long
Medicine Products: